Insights on Molecular Heterogeneity in Endometriosis Treatment – HER Heard
HER Heard shared a post by Femtech Insider on LinkedIn:
“Important breakthrough in our understanding of Endometriosis: ‘Endometriosis is currently classified based on symptoms and anatomical or surgical features, but these approaches don’t capture the biological programs active inside the tissue. Our work shows that what looks like unpredictable variability between patients actually reflects recurring cellular states that shape how the disease behaves and responds to treatment. This creates an opportunity to move toward more biologically informed patient stratification in research and clinical trials.'”
Quoting Femtech Insider’s post, adding:
“France-based biotech endogene.bio has published research suggesting that endometriosis is molecularly heterogeneous across patients, lesion sites, and cell types – a finding that could help explain why patients often experience different outcomes with the same therapy.
The preprint, titled ‘Beyond one-size-fits-all: single-cell transcriptomic signatures predict drug efficacy and reveal responder subgroups in endometriosis,’ combines single-cell RNA sequencing with a computational drug-response framework to identify distinct cellular response patterns that may predict which therapies are most likely to work for specific patient groups.
‘Endometriosis is currently classified based on symptoms and anatomical or surgical features, but these approaches don’t capture the biological programs active inside the tissue. Our work shows that what looks like unpredictable variability between patients actually reflects recurring cellular states that shape how the disease behaves and responds to treatment. This creates an opportunity to move toward more biologically informed patient stratification in research and clinical trials.’ Cristina Fernández Molina, Co-founder and Head of Science at endogene.bio
Full story.”
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
May 14, 2026, 17:13Ribociclib Plus Letrozole in Recurrent Low-Grade Serous Carcinoma of the Ovary – IJGC
-
May 14, 2026, 17:11Christopher Robinson: Isolated Severe Systolic Hypertension During Delivery Admission and Maternal Outcomes
-
May 14, 2026, 17:08Ally Murji: Honoured to Deliver the 51st Annual RT Weaver Lecture at McMaster University
-
May 14, 2026, 17:00Your Hair Dye Could Be Affecting Your Fertility – Fertility Plus
-
May 14, 2026, 16:53Devora Lieberman on Reduced-Tip Needle Design and Its Role in Egg Collection for Older Women – City Fertility
-
May 14, 2026, 16:48AI Can Watch Your IVF Embryo Grow and Predict If It’s Chromosomally Normal, Without Any Biopsy – Fertility Plus
-
May 14, 2026, 12:04Asma Khalil: Why Twin Pregnancies Need More Than Routine Monitoring?
-
May 14, 2026, 12:01Marco Zaccaria: Why Distension Media Selection Matters in Modern Hysteroscopy
-
May 14, 2026, 11:58Mathew Leonardi: PCOS Has Been Renamed to PMOS and It Changes How We Understand the Disease